Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by captatedon Nov 03, 2007 12:12am
229 Views
Post# 13745083

RE: Prometic is mentioned in PWC (mukimuk)

RE: Prometic is mentioned in PWC (mukimuk)Bepando, No: if you were interested in the material I referenced you would have invested the time you spent requesting a link instead finding the material for yourself. If you can't be bothered to do that you surely can't be expected to read it--much less invest the mental energies required to make sense of it. The nonsense going on here about this Blood publication and it's significance for the impact of 1402 on market sentiment reinforces my views above. That is, Pierre has stated his interest in the establishmnent of a new field of medical science, with respect to the 1402 trials to date: blood AND cancer. Well then, I think we pretty much have it. If, alternatively, he had said something to the effect that he was interested in sending the market cap of this co. to the moon and beyond then I think you might be halfway right about the value of 1402. That guy from marketing's email--the one referencing the value of the gloop HML might buy from PLI--is the only substantive clue I can discern about the direction of PLI income. Sorry for the negativity here, Bepando. I know it is unpleasant. I am not a fan of the current spirit of the times with respect to the currency of credibility. Want to know the source of the subprime crisis? It's not the lack of credibility of the rating agencies: it's their credibility. Credibility is another way of saying worthiness of belief--or credit, credulity. It is such a seriously messed up conceptual problem that I have very little hope of being understood by anyone here that could in some small way militate against my feelings of isolation. Boohoo, if only the prospect of going golfing with you dolts appealed to me I could laugh my way to the labotomy table.
Bullboard Posts